Should I buy or sell Life Science REIT stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Life Science REIT in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LABS shares. View LABS analyst ratings or view top-rated stocks .

What is Life Science REIT's stock price target for 2024?

1 brokerages have issued 12 month price targets for Life Science REIT's stock. Their LABS share price targets range from GBX 79 to GBX 79. On average, they anticipate the company's stock price to reach GBX 79 in the next year. This suggests a possible upside of 97.5% from the stock's current price. View analysts price targets for LABS or view top-rated stocks among Wall Street analysts .

How have LABS shares performed in 2024?

Life Science REIT's stock was trading at GBX 63.20 at the start of the year. Since then, LABS stock has decreased by 36.7% and is now trading at GBX 40. View the best growth stocks for 2024 here .

How often does Life Science REIT pay dividends? What is the dividend yield for Life Science REIT?

Life Science REIT declared a dividend on Tuesday, March 26th. Shareholders of record on Thursday, April 4th will be paid a dividend of GBX 1 per share on Monday, May 13th. This represents a yield of 2.32%. The ex-dividend date is Thursday, April 4th. The official announcement can be seen at this link . Read our dividend analysis for LABS .

Is Life Science REIT a good dividend stock?

Life Science REIT (LON:LABS) pays an annual dividend of GBX 4 per share and currently has a dividend yield of 7.09%. LABS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for LABS .

How do I buy shares of Life Science REIT?

Shares of LABS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:LABS

Life Science REIT (LABS) Share Price, News & Analysis

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)

Free LABS Stock Alerts

GBX 40

-0.20 (-0.50%)

(As of 05/8/2024 ET)

Today's Range: 39.70
▼
40.61
50-Day Range: 37.10
▼
45.80
52-Week Range: 37.10
▼
77.40

Volume: 606,325 shs
Average Volume: 940,090 shs
Market Capitalization: £140 million

P/E Ratio: N/A
Dividend Yield: 10.00%
Price Target: GBX 79

Stock Analysis Analyst Forecasts Chart Dividend

Get Life Science REIT alerts:

Life Science REIT MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 97.5% Upside
GBX 79 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.95 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Life Science REIT has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Life Science REIT has only been the subject of 1 research reports in the past 90 days.
Read more about Life Science REIT's stock forecast and price target.

N/A

Short Interest

Short Interest
There is no current short interest data available for LABS.

1.7

Dividend Strength

Dividend Leadership
Life Science REIT is a leading dividend payer. It pays a dividend yield of 7.09%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Life Science REIT does not have a long track record of dividend growth.
Read more about Life Science REIT's dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LABS.

0.6

News and Social Media Coverage

Search Interest
2 people have searched for LABS on MarketBeat in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Life Science REIT insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 6.04% of the stock of Life Science REIT is held by insiders.
Percentage Held by Institutions
74.04% of the stock of Life Science REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Read more about Life Science REIT's insider trading history.

0.7

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Life Science REIT is -500.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Life Science REIT has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad TradeSmith

The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

About Life Science REIT

LABS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LABS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive LABS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/13 Dividend: 4/04/2024
Today: 5/08/2024
Dividend Payable: 5/13/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: LON:LABS
CUSIP: N/A
CIK: N/A
Web: www.lifesciencereit.co.uk
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 79
High Stock Price Target: GBX 79
Low Stock Price Target: GBX 79
Potential Upside/Downside: +97.5%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX (0.08)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-29,190,000.00
Net Margins: -151.24%
Pretax Margin: N/A
Return on Equity: -8.24%
Return on Assets: 0.82%

Debt

Debt-to-Equity Ratio: 31.91
Current Ratio: 1.35
Quick Ratio: N/A

Sales & Book Value

Annual Sales: £19.30 million
Price / Sales: 7.25
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: GBX 90 per share
Price / Book: 0.44

Miscellaneous

Outstanding Shares: 350,000,000
Free Float: N/A
Market Cap: £140 million
Optionable: Not Optionable
Beta: 0.20

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Dr. Sally Ann Forsyth O.B.E.
Ph.D., Independent Non-Exec. Director & Sustainability Lead
Mr. Simon Farnsworth (Age 56)
Managing Director of Ironstone Asset Management Limited
Mr. David Lewis
Director of Operations & Fin. of Ironstone Asset Management Limited
Ms. Joanna Waddingham
Head of Investor Relations & Corp. Affairs of Ironstone Asset Management Limited
Ms. Stephanie Adams
Legal Counsel of Ironstone Asset Management Limited
Mr. Ian Harris
Director of Asset Management of Ironstone Asset Management Limited
Ms. Pippa Stacey
Head of ESG & Consultant of Ironstone Asset Management Limited
Tamara Deering
Head of Financial Planning & Reporting of Ironstone Asset Management Limited
Mr. Daniel Williams
Corp. & Devel. Financial Controller - Ironstone Asset Management Limited

LABS Stock Analysis - Frequently Asked Questions

Should I buy or sell Life Science REIT stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Life Science REIT in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LABS shares.
View LABS analyst ratings or view top-rated stocks.
What is Life Science REIT's stock price target for 2024?: 1 brokerages have issued 12 month price targets for Life Science REIT's stock. Their LABS share price targets range from GBX 79 to GBX 79. On average, they anticipate the company's stock price to reach GBX 79 in the next year. This suggests a possible upside of 97.5% from the stock's current price.
View analysts price targets for LABS or view top-rated stocks among Wall Street analysts.
How have LABS shares performed in 2024?: Life Science REIT's stock was trading at GBX 63.20 at the start of the year. Since then, LABS stock has decreased by 36.7% and is now trading at GBX 40.
View the best growth stocks for 2024 here.
How often does Life Science REIT pay dividends? What is the dividend yield for Life Science REIT?: Life Science REIT declared a dividend on Tuesday, March 26th. Shareholders of record on Thursday, April 4th will be paid a dividend of GBX 1 per share on Monday, May 13th. This represents a yield of 2.32%. The ex-dividend date is Thursday, April 4th. The official announcement can be seen at this link.
Read our dividend analysis for LABS.

Is Life Science REIT a good dividend stock?: Life Science REIT (LON:LABS) pays an annual dividend of GBX 4 per share and currently has a dividend yield of 7.09%. LABS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for LABS.
How do I buy shares of Life Science REIT?: Shares of LABS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:LABS) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Life Science REIT (LABS) Share Price, News & Analysis